Spectral Medical Inc. (TSE:EDT – Get Free Report) rose 2% during trading on Monday. The company traded as high as C$1.07 and last traded at C$1.02. 64,450 shares traded hands during trading, an increase of 22% from the average session volume of 52,794 shares. The stock had previously closed at C$1.00.
Spectral Medical Stock Up 2.0%
The stock’s fifty day moving average is C$1.10 and its two-hundred day moving average is C$1.30. The company has a current ratio of 0.61, a quick ratio of 0.45 and a debt-to-equity ratio of 26.03. The company has a market capitalization of C$299.43 million, a PE ratio of -34.00 and a beta of 0.86.
Spectral Medical (TSE:EDT – Get Free Report) last posted its quarterly earnings results on Friday, November 6th. The company reported C($0.01) earnings per share for the quarter. The company had revenue of C$0.28 million for the quarter. As a group, analysts predict that Spectral Medical Inc. will post -0.05 EPS for the current year.
Spectral Medical Company Profile
Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin¿ (‘PMX’). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s FDA cleared Endotoxin Activity Assay (EAA¿), the clinically available test for endotoxin in blood. PMX is approved for therapeutic use in Japan and Europe, licensed by Health Canada, and has been used safely and effectively with over 360,000 units sold worldwide to date.
Recommended Stories
- Five stocks we like better than Spectral Medical
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
